Global (United States, European Union and China) Pet Vaccine Market Research Report 2019-2025

Table of Contents

1 Pet Vaccine Market Overview

• 1.1 Product Overview and Scope of Pet Vaccine
• 1.2 Pet Vaccine Segment by Type
  • 1.2.1 Global Pet Vaccine Sales Growth Rate Comparison by Type (2021-2026)
  • 1.2.2 Attenuated Live Vaccines
  • 1.2.3 Conjugate Vaccines
  • 1.2.4 Inactivated Vaccines
  • 1.2.5 Subunit Vaccines
  • 1.2.6 Toxoid Vaccines
  • 1.2.7 DNA Vaccines
  • 1.2.8 Recombinant Vaccines
• 1.3 Pet Vaccine Segment by Application
  • 1.3.1 Pet Vaccine Sales Comparison by Application: 2020 VS 2026
  • 1.3.2 Canine
  • 1.3.3 Avian
  • 1.3.4 Feline
• 1.4 Global Pet Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Pet Vaccine Revenue 2015-2026
  • 1.4.2 Global Pet Vaccine Sales 2015-2026
  • 1.4.3 Pet Vaccine Market Size by Region: 2020 Versus 2026

2 Global Pet Vaccine Market Competition by Manufacturers

• 2.1 Global Pet Vaccine Sales Market Share by Manufacturers (2015-2020)
• 2.2 Global Pet Vaccine Revenue Share by Manufacturers (2015-2020)
• 2.3 Global Pet Vaccine Average Price by Manufacturers (2015-2020)
• 2.4 Manufacturers Pet Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Pet Vaccine Market Competitive Situation and Trends
  • 2.5.1 Pet Vaccine Market Concentration Rate
  • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
• 2.7 Primary Interviews with Key Pet Vaccine Players (Opinion Leaders)

3 Pet Vaccine Retrospective Market Scenario by Region

• 3.1 Global Pet Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
• 3.2 Global Pet Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
• 3.3 North America Pet Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Pet Vaccine Sales by Country
  • 3.3.2 North America Pet Vaccine Sales by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Pet Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Pet Vaccine Sales by Country
  • 3.4.2 Europe Pet Vaccine Sales by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Pet Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Pet Vaccine Sales by Region
  • 3.5.2 Asia Pacific Pet Vaccine Sales by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Pet Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Pet Vaccine Sales by Country
  • 3.6.2 Latin America Pet Vaccine Sales by Country
  • 3.6.3 Mexico
  • 3.6.3 Brazil
  • 3.6.3 Argentina
• 3.7 Middle East and Africa Pet Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Pet Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Pet Vaccine Sales by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Pet Vaccine Historic Market Analysis by Type

• 4.1 Global Pet Vaccine Sales Market Share by Type (2015-2020)
• 4.2 Global Pet Vaccine Revenue Market Share by Type (2015-2020)
• 4.3 Global Pet Vaccine Price Market Share by Type (2015-2020)
• 4.4 Global Pet Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Pet Vaccine Historic Market Analysis by Application

• 5.1 Global Pet Vaccine Sales Market Share by Application (2015-2020)
• 5.2 Global Pet Vaccine Revenue Market Share by Application (2015-2020)
• 5.3 Global Pet Vaccine Price by Application (2015-2020)

6 Company Profiles and Key Figures in Pet Vaccine Business

• 6.1 Bayer Healthcare
  • 6.1.1 Corporation Information
  • 6.1.2 Bayer Healthcare Description, Business Overview and Total Revenue
  • 6.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.1.4 Bayer Healthcare Products Offered
  • 6.1.5 Bayer Healthcare Recent Development
• 6.2 Vetoquinol S.A
  • 6.2.1 Vetoquinol S.A Pet Vaccine Production Sites and Area Served
  • 6.2.2 Vetoquinol S.A Description, Business Overview and Total Revenue
  • 6.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.2.4 Vetoquinol S.A Products Offered
  • 6.2.5 Vetoquinol S.A Recent Development
• 6.3 Boehringer Ingelheim
  • 6.3.1 Boehringer Ingelheim Pet Vaccine Production Sites and Area Served
  • 6.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
  • 6.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.3.4 Boehringer Ingelheim Products Offered
  • 6.3.5 Boehringer Ingelheim Recent Development
• 6.4 Ceva
  • 6.4.1 Ceva Pet Vaccine Production Sites and Area Served
  • 6.4.2 Ceva Description, Business Overview and Total Revenue
  • 6.4.3 Ceva Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Ceva Products Offered
  • 6.4.5 Ceva Recent Development
• 6.5 Eli Lilly
  • 6.5.1 Eli Lilly Pet Vaccine Production Sites and Area Served
  • 6.5.2 Eli Lilly Description, Business Overview and Total Revenue
  • 6.5.3 Eli Lilly Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.5.4 Eli Lilly Products Offered
  • 6.5.5 Eli Lilly Recent Development
• 6.6 Heska Co.
  • 6.6.1 Heska Co. Pet Vaccine Production Sites and Area Served
  • 6.6.2 Heska Co. Description, Business Overview and Total Revenue
  • 6.6.3 Heska Co. Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.6.4 Heska Co. Products Offered
  • 6.6.5 Heska Co. Recent Development
• 6.7 Merck Animal Health
  • 6.6.1 Merck Animal Health Pet Vaccine Production Sites and Area Served
  • 6.6.2 Merck Animal Health Description, Business Overview and Total Revenue
  • 6.6.3 Merck Animal Health Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.4.4 Merck Animal Health Products Offered
  • 6.7.5 Merck Animal Health Recent Development
• 6.8 Merial (Sanofi)
  • 6.8.1 Merial (Sanofi) Pet Vaccine Production Sites and Area Served
  • 6.8.2 Merial (Sanofi) Description, Business Overview and Total Revenue
  • 6.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.8.4 Merial (Sanofi) Products Offered
  • 6.8.5 Merial (Sanofi) Recent Development
• 6.9 Virbac
  • 6.9.1 Virbac Pet Vaccine Production Sites and Area Served
  • 6.9.2 Virbac Description, Business Overview and Total Revenue
  • 6.9.3 Virbac Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.9.4 Virbac Products Offered
  • 6.9.5 Virbac Recent Development
• 6.10 Zoetis (Pfizer)
  • 6.10.1 Zoetis (Pfizer) Pet Vaccine Production Sites and Area Served
  • 6.10.2 Zoetis (Pfizer) Description, Business Overview and Total Revenue
  • 6.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue and Gross Margin (2015-2020)
  • 6.10.4 Zoetis (Pfizer) Products Offered
  • 6.10.5 Zoetis (Pfizer) Recent Development

7 Pet Vaccine Manufacturing Cost Analysis

• 7.1 Pet Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Raw Materials Price Trend
  • 7.1.3 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Pet Vaccine
• 7.4 Pet Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Pet Vaccine Distributors List
• 8.3 Pet Vaccine Customers

9 Market Dynamics

• 9.1 Market Trends
• 9.2 Opportunities and Drivers
• 9.3 Challenges
• 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

• 10.1 Global Pet Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Pet Vaccine by Type (2021-2026)
  • 10.1.2 Global Forecasted Revenue of Pet Vaccine by Type (2021-2026)
• 10.2 Pet Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Pet Vaccine by Application (2021-2026)
  • 10.2.2 Global Forecasted Revenue of Pet Vaccine by Application (2021-2026)
• 10.3 Pet Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Pet Vaccine by Region (2021-2026)
  • 10.3.2 Global Forecasted Revenue of Pet Vaccine by Region (2021-2026)
• 10.4 North America Pet Vaccine Estimates and Projections (2021-2026)
• 10.5 Europe Pet Vaccine Estimates and Projections (2021-2026)
• 10.6 Asia Pacific Pet Vaccine Estimates and Projections (2021-2026)
• 10.7 Latin America Pet Vaccine Estimates and Projections (2021-2026)
• 10.8 Middle East and Africa Pet Vaccine Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List